James H. Schluger

Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addiction

Cherie E. Bond, K. Steven LaForge, Mingting Tian et al. · Proceedings of the National Academy of Sciences · 1998 · 1.1K citations

Medicine, Molecular Genetics, Pharmacology +17

Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers: Partial Kappa Opioid Agonist Activity?

Gavin Bart, James H. Schluger, Lisa Borg et al. · Neuropsychopharmacology · 2005 · 139 citations

Medicine, Endocrinology, Pharmacology +13

Opioid Receptor Imaging with Positron Emission Tomography and [18F]Cyclofoxy in Long-Term, Methadone-Treated Former Heroin Addicts

Mitchel A. Kling, Richard E. Carson, Lisa Borg et al. · Journal of Pharmacology and Experimental Therapeutics · 2000 · 119 citations

Medicine, Pharmacology, Pharmacotherapy +17

Nalmefene Causes Greater Hypothalamic‐Pituitary‐Adrenal Axis Activation than Naloxone in Normal Volunteers: Implications for the Treatment of Alcoholism

James H. Schluger, Ann Ho, Lisa Borg et al. · Alcoholism Clinical and Experimental Research · 1998 · 93 citations

Medicine, Endocrinology, Pharmacology +16

Dynorphin A1–13 Causes Elevation of Serum Levels of Prolactin Through an Opioid Receptor Mechanism in Humans: Gender Differences and Implications for Modulation of Dopaminergic Tone in the Treatment of Addictions

Mary Jeanne Kreek, James H. Schluger, L.A.H. Borg et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 91 citations

Medicine, Endocrinology, Pharmacology +17